Yangjingyi Ruan

Yangjingyi Ruan is a Pharmacology PhD candidate at Weill Cornell/MSK who uses CRISPR, proteomics, and drug combinations to find synthetic-lethal targets and develop new combination therapies for oncology. 

At Traverse, she looks to engage deeply in science commercialization while providing her outsized enthusiasm to the team.

Yangjingyi received her BS in Molecular, Cell, and Developmental Biology from the University of California, Los Angeles.